invoX
invoX Pharma is a research-driven biopharmaceutical company developing complex respiratory drug-device combination products using its proprietary Softhaler® soft mist inhaler platform.
invoX Pharma develops innovative and generic drug-device combination products using a proprietary next-generation soft mist inhaler platform called Softhaler®. The company maintains a flexible supply chain offering development through commercial supply services, and has a diversified pipeline of clinical and pre-clinical stage respiratory drug candidates.
Key People
- Ben Toogood - Chief Executive Officer